Trial Profile
Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: 'QOL Survey in Premenopausal Breast Cancer Patients'
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Takeda
- 02 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 May 2014 New trial record